Search

everythinglearnresearchcommunity

for

Search:↓

The Princeton III Consensus recommends assessing cardiovascular risk in men with erectile dysfunction and prioritizing heart health before treating ED, especially in those with potential heart disease.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Stromal Vascular Fraction might help with male sexual dysfunction, but more research is needed to confirm its safety and effectiveness.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Patients should consult urologists for evidence-based erectile dysfunction treatments.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Serum IMA levels may be linked to premature hair graying and erectile dysfunction.

Men with prediabetes have worse sexual health and a higher risk of severe erectile dysfunction.

Testosterone levels are not linked to erectile dysfunction in young and middle-aged men with HIV.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

A new syndrome was linked to two new genetic changes in the MBTPS1 gene in a 14-year-old girl.

Men may experience long-term sexual dysfunction after stopping Finasteride.

Long use of finasteride and dutasteride can cause long-term erection problems.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

Doxazosin and finasteride negatively affect sexual function in men with BPH.